New Topical Hemp Pain Relievers


HempFusion® ("the Company"), a leading dietary supplements company focused on products that contain Hemp/CBD in the United States with distribution of its family of brands to approximately 4,000 retailers across 47 states, is pleased to announce the launch of its Food and Drug Administration ("FDA") listed Over-the-Counter ("OTC") Topical Products featuring scientifically documented active ingredients targeting specific consumer needs including menthol, salicylic acid, and colloidal oatmeal, providing relief for pain, acne, eczema and more.

HempFusion is excited to offer consumers access to FDA listed topical solutions, backed by scientifically documented active ingredients formulated in a proprietary cosmetic ingredient base. This includes aloe vera, jojoba oil, shea butter, essential oils and HempFusion's premium panoramic Full-Spectrum hemp extract featuring CBD and other naturally occurring cannabinoids as well as terpenes for their skin conditioning and moisturizing benefits, and so much more.

 "With the launch of our innovative OTC Topicals line, HempFusion provides consumers with high quality OTC products that are backed by science", stated Jason Mitchell, N.D., Co-CEO of HempFusion. "By producing and marketing these products in accordance with the FDA's OTC regulations, we are able to utilize active ingredients that target specific conditions for a variety of consumer needs, which we believe has the ability to substantially increase our customer base", continued Mitchell. 

The Company's OTC Topical line, now available on www.hempfusion.com, provides consumers with a wide selection of creams and balms, including an ointment and gel, specifically targeting the following:

Pain Relief:

  • Pain Relief Cream
  • Pain Relief Balm
  • Sports Pain Relief Cream
  • Sports Pain Relief Balm
  • Pain Relief Gel including moisturizing Arnica Extract

HempFusion Formulas for Skin Conditions:

  • Eczema Relief Cream
  • Acne Relief Cream
  • Wound Ointment Antibiotic First Aid

"We believe these new product offerings will increase our customer base by providing  concerned retailers with the ability to stock our OTC Topicals with confidence that these products follow the FDA's OTC guidelines," added Ian deQueiroz Co-CEO of HempFusion. "We anticipate this specialized line has the potential to be a significant revenue driver and division of the Company," continued deQueiroz.


Be the first to review this item!


Bookmark this

12 Jun 2020


By Press Release
Advertisement